First patient treated with CSI’s new peripheral support catheter

Michael Walter | | Cardiovascular Business | Peripheral Artery Disease
surgery-676375_1920.jpg

Cardiovascular Systems, Inc. (CSI), a Minnesota-based healthcare technology company focused on treating peripheral artery disease (PAD) and coronary artery disease (CAD), announced that the first patient has been treated with its ViperCross peripheral support catheter.

Billy J. Kim, MD, a vascular surgeon at the Surgical Clinic in Nashville, completed the procedure.

“With the commercial launch of ViperCross, CSI now offers a complete portfolio of products for the treatment of PAD, including atherectomy, balloon catheters, guidewires, support catheters and embolic protection,” Scott R. Ward, chairman, president and CEO of CSI, said in a statement. “Combined, these products advance our ability to help physicians improve outcomes for patients undergoing complex peripheral interventions.”

“ViperCross offers the right balance of support and flexibility to successfully navigate tortuous anatomy and cross challenging lesions,” Kim added. “In addition, ViperCross provides excellent guidewire support and facilitates easy guidewire exchange.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

New-look peripheral stent with expandable spikes receives FDA’s de novo classification
Late-breaking cardiovascular drug trials took center stage at ACC.25
‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes
Safety update: FDA announces Class I recall due to atherectomy devices breaking during use
Advances in bioresorbable stents show promise for treating PAD
FDA clears first generic versions of rivaroxaban—what it means for patient care

Around the web

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business
U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.